NCT06717659 Probiotics in Pulmonaty Rehabilitation for COPD
| NCT ID | NCT06717659 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fu Jen Catholic University |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-12-05 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-12-05 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate various aspects of patients with chronic respiratory diseases undergoing pulmonary rehabilitation supplemented with probiotics. The focus will be on clinical physiological responses, functional performance, respiratory status assessments, nutritional status evaluations, body composition analyses, and biochemical blood parameters, with a primary emphasis on the anti-inflammatory response.
Eligibility Criteria
Inclusion Criteria: * Willing to sign a written informed consent form. * Diagnosed with pre-COPD or COPD stage I-IV according to the 2023 GOLD guidelines. * Undergoing pulmonary rehabilitation therapy for more than three months. Exclusion Criteria: * Under 18 years old. * Diagnosed with neuromuscular diseases. * Experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months. * Unable to cooperate with cardiopulmonary exercise testing. * Has other diseases or behavioral restrictions preventing participation in exercise training for over one year. * Assessed by a physician to have severe malnutrition or a significantly low BMI.
Contact & Investigator
Ke-Yun Chao, PhD
PRINCIPAL INVESTIGATOR
Fu Jen Catholic University
Frequently Asked Questions
Who can join the NCT06717659 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06717659 currently recruiting?
Yes, NCT06717659 is actively recruiting participants. Contact the research team at C00152@mail.fjuh.fju.edu.tw for enrollment information.
Where is the NCT06717659 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT06717659 clinical trial?
NCT06717659 is sponsored by Fu Jen Catholic University. The principal investigator is Ke-Yun Chao, PhD at Fu Jen Catholic University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.